The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Oxyntomodulin Inhibits Food Intake in the Rat
Abstract
Oxyntomodulin is derived from proglucagon processing in the intestine and the central nervous system. To date, no role in the central nervous system has been demonstrated. We report here that oxyntomodulin inhibits refeeding when injected intracerebroventricularly and into the hypothalamic paraventricular nucleus of 24-h fasted rats [intracerebroventricularly and into the paraventricular nucleus, 1 h, oxyntomodulin (1 nmol), 3.1 +/- 0.5 g; saline, 6.2 +/- 0.4 g; P < 0.005]. In addition, oxyntomodulin inhibits food intake in nonfasted rats injected at the onset of the dark phase (intracerebroventricularly, 1 h: oxyntomodulin, 3 nmol, 1.1 +/- 0.19 g vs. saline, 2.3 +/- 0.2 g; P < 0.05). This effect of oxyntomodulin on feeding is of a similar time course and magnitude as that of an equimolar dose of glucagon-like peptide-1. Other proglucagon-derived products investigated [glucagon, glicentin (intracerebroventricularly, 3 nmol; into the paraventricular nucleus, 1 nmol), and spacer peptide-1 (intracerebroventricularly and into the paraventricular nucleus, 3 nmol)] had no effect on feeding at any time point examined. The anorectic effect of oxyntomodulin (intracerebroventricularly, 3 nmol; into the paraventricular nucleus, 1 nmol) was blocked when it was coadministered with the glucagon-like peptide-1 receptor antagonist, exendin-(9-39) (intracerebroventricularly, 100 nmol; into the paraventricular nucleus, 10 nmol). However, oxyntomodulin has a lower affinity for the glucagon-like peptide-1 receptor compared with glucagon-like peptide-1 (IC(50): oxyntomodulin, 8.2 nM; glucagon-like peptide-1, 0.16 nM). One explanation for this is that there might be an oxyntomodulin receptor to which exendin-(9-39) can also bind and act as an antagonist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Self-citationMENTLEIN, R., GALLWITZ, B., & SCHMIDT, W. E. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17986.x · Cited by 1,161
Eng, J., Kleinman, W. A., Singh, L., Singh, G., & Raufman, J. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42531-8 · Cited by 1,000
Göke, R., Fehmann, H. C., Linn, T., Schmidt, H., Krause, M., Eng, J., & Göke, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36565-2 · Cited by 837
Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724
Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats
Tang-Christensen, M., Larsen, P. J., Goke, R., Fink-Jensen, A., Jessop, D. S., Moller, M., & Sheikh, S. P. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.4.r848 · Cited by 597
Thorens, B., Porret, A., Bühler, L., Deng, S.-P., Morel, P., & Widmann, C. (1993) · Diabetes · doi:10.2337/diab.42.11.1678 · Cited by 558
Göke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474 · cited 1×
“However, when administered into the rat cerebroventricular system (ICV), GLP-1 acts a potent inhibitor of food intake (8 –10) The paraventricular nucleus (PVN) of the hypothalamus is an area involved in the control of food intake and has a high density of GLP-1 receptors (GLP-1R) (11, 12).”
BackgroundYoung, A. A., Gedulin, B. R., Bhavsar, S., Bodkin, N., Jodka, C., Hansen, B., & Denaro, M. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1026 · Cited by 440
Edwards, C., Abusnana, S., Sunter, D., Murphy, K., Ghatei, M., & Bloom, Sr. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.160r007 · Cited by 434
Self-citationEdwards, C. M., Todd, J. F., Mahmoudi, M., Wang, Z., Wang, R. M., Ghatei, M. A., & Bloom, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.86 · Cited by 344
Self-citationPrototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2
Munroe, D. G., Gupta, A. K., Kooshesh, F., Vyas, T. B., Rizkalla, G., Wang, H., Demchyshyn, L., Yang, Z.-J., Kamboj, R. K., Chen, H., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1569 · Cited by 328
Tang-Christensen, M., Larsen, P. J., Thulesen, J., Rømer, J., & Vrang, N. (2000) · Nature Medicine · doi:10.1038/77535 · Cited by 269
Role of prohormone convertases in the tissue-specific processing of proglucagon
Dhanvantari, S. (1996) · Molecular Endocrinology · doi:10.1210/me.10.4.342 · Cited by 242
Navarro, M., De Fonseca, F. R., Alvarez, E., Chowen, J. A., Zueco, J. A., Gomez, R., Eng, J., & Blázquez, E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67051982.x · Cited by 233
Kim, M. S., Rossi, M., Abusnana, S., Sunter, D., Morgan, D. G., Small, C. J., Edwards, C. M., Heath, M. M., Stanley, S. A., Seal, L. J., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.2.177 · Cited by 216
Self-citationMcMahon, L. R., & Wellman, P. J. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.1.r23 · Cited by 199
Glucagon-like peptide-1 is a physiological incretin in rat.
Wang, Z., Wang, R. M., Owji, A. A., Smith, D. M., Ghatei, M. A., & Bloom, S. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117671 · Cited by 190
Self-citationGreig, N. H., Holloway, H. W., De Ore, K. A., Jani, D., Wang, Y., Zhou, J., Garant, M. J., & Egan, J. M. (1999) · Diabetologia · doi:10.1007/s001250051111 · Cited by 189
Bataille, D., Coudray, A. M., Carlqvist, M., Rosselin, G., & Mutt, V. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)80708-4 · Cited by 161
Kalra, S. P., Dube, M. G., Fournier, A., & Kalra, P. S. (1991) · Physiology & Behavior · doi:10.1016/0031-9384(91)90490-f · Cited by 135
Oxyntomodulin from distal gut: Role in regulation of gastric and pancreatic functions
Schjoldager, B., Mortensen, P. E., Myhre, J., Christiansen, J., & Holst, J. J. (1989) · Digestive Diseases and Sciences · doi:10.1007/bf01538078 · Cited by 132
Gros, L., Thorens, B., BATAILLE, D., & Kervran, A. (1993) · Endocrinology · doi:10.1210/endo.133.2.8102095 · Cited by 121
The glucagon superfamily: Precursor structure and gene organization
Bell, G. I. (1986) · Peptides · doi:10.1016/0196-9781(86)90160-9 · Cited by 118
Serre‐Beinier, V., Dolci, W., Schaerer, E., Scrocchi, L. A., Drucker, D. J., Efrat, S., & Thorens, B. (1998) · Endocrinology · doi:10.1210/endo.139.11.6295 · Cited by 113
Autoradiographic localization of receptors for glucagon-like peptide-1(7–36) amide in rat brain
UTTENTHAL, L. O., Tolédano, A., & Blázquez, E. (1992) · Neuropeptides · doi:10.1016/0143-4179(92)90036-v · Cited by 96
BATAILLE, D., Gespach, C. P., Tatemoto, K., Marie, J., Coudray, A. M., Rosselin, G., & Mutt, V. (1981) · Peptides · doi:10.1016/0196-9781(81)90008-5 · Cited by 94
Glicentin inhibits gastric acid secretion in the rat
Kirkegaard, P. O., Moody, A. J., Holst, J. J., Loud, F. B., Olsen, P. S., & Christiansen, J. (1982) · Nature · doi:10.1038/297156a0 · Cited by 88
Biological activity of GLP-1-analogues with N-terminal modifications
Siegel, E. G., Gallwitz, B., Scharf, G., Mentlein, R., Morys‐Wortmann, C., Fölsch, U. R., Schrezenmeir, J., Drescher, K., & Schmidt, W. E. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00155-4 · Cited by 83
Beak, S. A., Small, C. J., Иловайская, И. А., Hurley, J. D., Ghatei, M. A., Bloom, S. R., & Smith, D. M. (1996) · Endocrinology · doi:10.1210/endo.137.10.8828468 · Cited by 71
Self-citationSchepp, W., Schmidtler, J., Riedel, T., Dehne, K., SCHUSDZIARRA, V., Holst, J. J., Eng, J., Raufman, J., & Classen, M. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90085-x · Cited by 66
Glucagon-like peptide-1 (7–36 amide): a potent glucagonostatic and insulinotropic hormone
Matsuyama, T., Komatsu, R., Namba, M., Watanabe, N., Itoh, H., & Tarui, S. (1988) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(88)80063-9 · Cited by 64
Schepp, W., Dehne, K., Riedel, T., Schmidtler, J., Schaffer, K., & Classen, M. (2009) · Digestion · doi:10.1159/000201367 · Cited by 56
Sunter, D., Morgan, I., Edwards, C. M. B., Dakin, C. L., Murphy, K. G., Gardiner, J., Taheri, S., Rayes, E., & Bloom, S. R. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02344-7 · Cited by 53
Self-citationOxyntomodulin (glucagon‐37) and its C‐terminal octapeptide inhibit gastric acid secretion
Jarrousse, C., Audousset-Puech, M.-P., Dubrasquet, M., Niel, H., Martínez, J., & BATAILLE, D. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80879-6 · Cited by 50
Oxyntomodulin and Glicentin: Brain-Gut Peptides in the Rat*
Blache, P., Kervran, A., & BATAILLE, D. (1988) · Endocrinology · doi:10.1210/endo-123-6-2782 · Cited by 46
Siegel, Scharf, Gallwitz, Mentlein, Morys‐Wortmann, Fölsch, & Schmidt (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00440.x · Cited by 24
Bonnet, C., Jarrousse, C., Niel, H., Martínez, J., & BATAILLE, D. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90720-b · Cited by 20
BATAILLE, D., Tatemoto, K., Am, C., Rosselin, G., & Mutt, V. (1981) · PubMed · Cited by 14
H-Lys-Arg-Asn-Lys-Asn-Asn-OH is the minimal active structure of oxyntomodulin
Carles-Bonnet, C., Martínez, J., Jarrousse, C., Aumelas, A., Niel, H., & BATAILLE, D. (1996) · Peptides · doi:10.1016/0196-9781(96)00001-0 · Cited by 13
N-acetyl oxyntomodulin30?37: pharmacokinetics and activity on gastric acid secretion
Carles-Bonnet, C., Jarrousse, C., Niel, H., Martínez, J., Rolland, M., & BATAILLE, D. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00175470 · Cited by 8
Cited by
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Gastrointestinal regulation of food intake
Cummings, D. E., & Overduin, J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30227 · Cited by 1,216
Gut hormones and the regulation of energy homeostasis
Murphy, K. G., & Bloom, S. R. (2006) · Nature · doi:10.1038/nature05484 · Cited by 778
“Oxyntomodulin has a roughly 50-fold lower affinity for the GLP-1 receptor than GLP-1, but seems to reduce food intake with similar potenc”
BackgroundUpdate on the treatment of type 2 diabetes mellitus
Marín-Peñalver, J. J., Martín-Timón, I., Sevillano-Collantes, C., & Cañizo-Gómez, F. J. D. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i17.354 · Cited by 647
Metadata
- Authors
- Dakin, C. L., Gunn, I., Small, C. J., Edwards, C. M. B., Hay, D. L., Smith, D. M., Ghatei, M. A., & Bloom, S. R.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2001-10-01
- Volume
- 142
- Issue
- 10
- Pages
- 4244-4250
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2132144189
- Cited by
- 281
- References
- 41
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.